Latest Flu pandemic Stories

Design Enables More Rapid Response to Potential Pandemics LA JOLLA, Calif. and ROCKVILLE, Md., May 15, 2013 /PRNewswire/ -- A team of international researchers from the J. Craig Venter Institute (JCVI), Synthetic Genomics Inc. (SGI), Novartis Vaccines and Diagnostics, the Biomedical Advanced Research and Development Authority (BARDA, US Department of Health and Human Services), and Institut fur Virologie, Phillips Universitat, has published a study detailing new methods to rapidly generate...

BEIJING, May 15, 2013 /PRNewswire/ -- Sinovac Biotech Ltd. (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, has appointed China-based Ernst & Young Hua Ming LLP as its registered independent public accounting firm effective from May 14, 2013 to replace Ernst & Young LLP Canada. On May 14, 2013, Ernst & Young LLP Canada notified the Company that it would not stand for re-election as the Company's registered independent public accounting firm....

BEIJING, May 14, 2013 /PRNewswire/ -- Sinovac Biotech Ltd. (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced today that management is scheduled to present at the UBS Global Healthcare Conference in New York City. The Sinovac management team inclusive of Nan Wang, Vice President, and Helen Yang, Director, Investor Relations and International Business Development, will present at 10:00 am ET on Monday, May 20, 2013. About Sinovac Sinovac...

44% of adults had flu shots and 14% of adults had the flu NEW YORK, May 14, 2013 /PRNewswire/ -- Last winter's flu season was fairly typical of other winters over the last decade, with the prevalence of the flu and the number of people who had flu shots both fairly close to the averages for that time period. The effectiveness of flu vaccines also seems to have been fairly typical. (Logo: http://photos.prnewswire.com/prnh/20100517/NY06256LOGO ) These are some of the findings of...

NES ZIONA, Israel, May 13, 2013 /PRNewswire/ -- NanoPass Technologies Ltd. ("NanoPass"), a pioneer in intradermal (into-the-skin or ID) vaccine delivery solutions, is collaborating with the US Center of Disease Control and prevention (CDC) in conducting a large phase 3 trial of polio vaccine in infants in South East Asia. This collaboration is a part of NanoPass's long-term commitment to improve Global Health by providing access to its vaccine delivery devices....

LA JOLLA, Calif., May 7, 2013 /PRNewswire-USNewswire/ -- The Scripps Research Institute (TSRI) today announced a five-year agreement with Janssen Pharmaceuticals, Inc. (Janssen) to collaborate on focused research projects in the infectious disease area, with the initial project targeting the influenza virus. Under the agreement Janssen will receive certain license rights to the results of the research. Janssen Pharmaceuticals will collaborate in the research on influenza through its...

Ensuring hospital staff safety is paramount to hospital operational sustainability during a pandemic. WASHINGTON, April 29, 2013 /PRNewswire/ -- The outbreak of the new H7N9 bird flu in China, which the WHO called "an unusually dangerous virus for humans," should be an incentive for a renewed look at infection control procedures and pandemic readiness, which includes proper protection of health care staff. Taiwanese news agency CNA is reporting that "3 hospital staff show symptoms...

MISSISSIPPI STATE, Miss., April 25, 2013 /PRNewswire-USNewswire/ -- Pandemic flu continues to threaten public health, especially in the wake of the recent emergence of an H7N9 low pathogenic avian influenza strain in humans. A recent study published in PLoS ONE, a peer-reviewed scientific journal, provides new information for public health officials on mitigating the spread of infection from emerging flu viruses. Dr. Henry Wan, associate professor at the Mississippi State University...

Brett Smith for redOrbit.com – Your Universe Online By analyzing sewage, a group of European researchers was able to determine that about half of the Tamiflu prescribed during the 2009-2010 influenza pandemic went unused in England. The team’s findings, which were published in the open access journal PLOS ONE, could be used to inform the next pandemic reaction by health officials and served as validation for the novel method used to measure widespread prescription drug compliance....

New assays are a powerful tool for enhanced influenza virus surveillance, say researchers in The Journal of Molecular Diagnostics Over 40,000 people die each year in the United States from influenza-related diseases. In patients whose immune systems are compromised, antiviral therapy may be life-saving, but it needs to be initiated quickly. It is therefore crucial to diagnose and type the influenza rapidly. Scientists in the Netherlands have designed and evaluated a set of molecular assays...